The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC).
 
Jonathan Spicer
Honoraria - AstraZeneca; Bristol Myers Squibb Foundation; Merck
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation
Research Funding - AstraZeneca; Merck; Roche
 
Changli Wang
No Relationships to Disclose
 
Fumihiro Tanaka
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Covidien; Johnson & Johnson; Lilly Japan; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
Research Funding - Boehringer Ingelheim; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
 
Gene Brian Saylors
No Relationships to Disclose
 
Ke-Neng Chen
No Relationships to Disclose
 
Moishe Liberman
Honoraria - Boston Scientific; Ethicon; Novartis; Olympus
Consulting or Advisory Role - Ethicon; Olympus
Research Funding - AstraZeneca; Boston Scientific; Cook Medical; Ethicon; Merck; Novartis
 
Everett E. Vokes
Stock and Other Ownership Interests - Coordination Pharmaceuticals
Honoraria - Abbvie; Ascendis Pharma (I); AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Radius Health (I); Takeda (I)
Consulting or Advisory Role - Abbvie; Ascendis Pharma (I); AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis; Radius Health (I); Takeda (I)
Research Funding - Abbvie; Bristol-Myers Squibb; Celgene; Lilly (Inst); Novartis
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; BeiGene; BioNTech; EMD Serono; Genentech; GlaxoSmithKline; Lilly; Merck; Novartis
 
Nicolas Girard
Employment - AstraZeneca (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Lilly; MSD; Novartis; Pfizer; Pharmamar; Roche; Sanofi; Takeda
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; MSD Oncology; Roche
 
Shun Lu
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; GenomiCare; Hutchison MediPharma; Menarini; Pfizer; PrIME Oncology; Roche; Simcere Pharmaceutical Group; Yuhan; Zai Lab
Speakers' Bureau - AstraZeneca; Hansoh; Hengrui Therapeutics; Roche
Research Funding - AstraZeneca; BMS; Hansoh; HenRui; Hutchison MediPharma; Roche
 
Mariano Provencio
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Expert Testimony - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; MSD; Roche; Takeda
 
Tetsuya Mitsudomi
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Daiichi-Sankyo; Ethicon; Guardant Health; Janssen Oncology; Kyowa Hakko Kirin; Lilly; Merck KGaA; Merck KGaA; MSD K.K; Novartis; Ono Pharmaceutical; Pfizer; Taiho Pharmaceutical; Takeda; Thermofisher Scientific Biomarkers
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Daiichi Sankyo; Lilly; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Thermo Fisher Scientific
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Kyowa Hakko Kirin (Inst); MSD K.K (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi/Aventis (Inst); Taiho Pharmaceutical (Inst)
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; Achilles Therapeutics; Archer; ARIAD; AstraZeneca; AstraZeneca/MedImmune; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; EMD Serono; Foundation Medicine; Genentech; Gritstone Bio; Hengrui Therapeutics; Maverick Therapeutics; Merck; Mirati Therapeutics; Nektar; Neon Therapeutics; NextCure; Novartis; Panasonic; Pfizer; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst)
 
Enriqueta Felip
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bayer; Blueprint Medicines; Boehringer Ingelheim; Bristol Myers Squibb; Genzyme; GlaxoSmithKline; Janssen; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Puma Biotechnology; Roche; Sanofi; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol Myers Squibb; CME outfitters; Lilly; Medscape; Merck Sharp & Dohme; Novartis; PeerVoice; Pfizer; Prime Oncology; Roche; Springer; Takeda; touchIME
Research Funding - EMD Serono (Inst); Merck (Inst)
Other Relationship - GRÍFOLS
 
Patrick M. Forde
Consulting or Advisory Role - Abbvie; Amgen; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/UCB Japan; Janssen
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals; Kyowa Hakko Kirin (Inst); Novartis (Inst)
 
Scott Swanson
Honoraria - Covidien
Consulting or Advisory Role - Ethicon
 
Julie R. Brahmer
Honoraria - Roche/Genentech
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Lilly; Merck; Regeneron; Sanofi
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); RAPT Therapeutics (Inst); Revolution (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech
Other Relationship - Bristol-Myers Squibb; Janssen Oncology; merck
 
Keith Kerr
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Debiopharm Group; Diaceutics; Lilly; MSD Oncology; Novartis; Pfizer; Regeneron; Roche/Genentech
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Novartis; pfizer; Roche/Genentech
 
Cécile Dorange
Employment - Bristol Myers Squibb
Stock and Other Ownership Interests - Bristol Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Junliang Cai
Employment - Bristol-Myers Squibb
 
Stephen Broderick
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Speakers' Bureau - AstraZeneca